LSLama Shamseddine

Lama Shamseddine

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lama Shamseddine has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The broad-spectrum RumC1 bacteriocin targets a transient peptidoglycan intermediate of the nascent cell wall

    by Anne Boyeldieu, Mathilde Vallette, Mathieu Bergé, Clarisse Roblin, Lama Shamseddine, Anna M. Diaz-Rovira, Anne-Lise Soulet, Christian Basset, Lauriane Plouhinec, Agnès Amouric, et al.

    Ruminoccocin C1 (RumC1) is a structurally unique bacteriocin with broad-spectrum efficacy, including against multidrug-resistant pathogens, yet acting by an undefined mechanism. By integrating genetics, biochemistry, computational modeling, and single-cell fluorescence microscopy, we demonstrate that RumC1 is a distinct cell-wall-targeting toxin. First, all RumC1-resistant mutants isolated through a high-rate, genome-wide mutagenic screening exhibited specific impairments in peptidoglycan homeostasis regulation, pinpointing this pathway as critical for RumC1 activity. Second, RumC1 selectively accumulates within neosynthesized peptidoglycan, leading to cell growth arrest and death in a dose-dependent manner. Third, we characterize the RumI c 1 immunity protein of the RumC1 biosynthetic cluster as a peptidase acting at the cell surface to protect the cells by trimming the stem peptide crucial for cell-wall assembly. As such, RumI c 1 provides cross-protection against vancomycin, while RumC1 is demonstrated to act differently from this glycopeptide antibiotic. Collectively, these findings establish RumC1 as a toxin targeting a key peptidoglycan intermediate of cell wall maturation, which defines a distinct mode of action among the large and highly diverse repertoire of bacteriocins characterized so far.

  • Open Access

    Elongasome Dysfunction Triggers Dependence on MepM-Mediated Peptidoglycan Recycling

    by Lama Shamseddine, Manon Janet-Maitre, Asmaa Yousra Chikhi, Harinderbir Kaur, Jean-Luc Pellequer, Ina Attrée, Viviana Job

    The bacterial peptidoglycan (PG) layer is responsible for maintaining cell shape and protecting the cell against both external stress and internal turgor pressure. In rod-shaped bacteria, PG synthesis is orchestrated by two major multi-protein complexes: the elongasome and the divisome, which drive lateral and septal cell wall synthesis, respectively. The membrane protein MreD plays a central role in regulating the elongasome activity. Here, we leveraged a viable Pseudomonas aeruginosa transposon mutant, with reduced mreD expression, to dissect cellular adaptations to impaired elongasome function. A genome-wide synthetic lethality screen revealed that cell division and PG recycling pathways become essential in the context of an impaired elongasome machinery. Moreover, Tn-seq analysis identified the endopeptidase MepM as essential in the mreD downregulated background, whereas its overexpression promoted cell elongation in the parental strain, supporting a conserved role in lateral wall biogenesis. We demonstrate that MepM sustains viability during elongasome impairment by maintaining an active MurU-dependent PG recycling pathway. Together, our findings uncover a functional coupling between PG hydrolysis, recycling, and synthesis. We also identify MepM and PG recycling as critical determinants of bacterial survival when elongasome activity is compromised, positioning these pathways as attractive targets for the development of next-generation or combinatory antibacterial therapies.

  • Characterization of the Thioether Bonds - Containing Peptides of Ruminococcus gnavus E1

    by Lama Shamseddine

    Caractérisation des peptides à ponts thioéthers chez Ruminococcus gnavus E1: L'émergence de souches bactériennes résistantes aux antibiotiques est considérée comme l'une desprincipales menaces en santé humaine. Cette situation pousse les scientifiques à trouver de nouvellesmolécules, idéalement naturelles, avec des structures et des modes d'action différents pour contrer lesphénomènes de résistance. Dans ce contexte, les peptides antimicrobiens et notamment les peptidessynthétisés par voie ribosomique et modifiés post-traductionnellement (RiPPs) constituent unealternative prometteuse. Dans ce projet, nous nous sommes concentrés sur les RiPPs contenant desliaisons thioéther. Le travail a porté sur deux types de peptides produits par un membre dominant dumicrobiote intestinal humain, Ruminococcus gnavus E1 : les sactipeptides RumCs et le ranthipeptideRgSCIFF. Les cinq isoformes RumCs (RumC1-5) ont été produits de manière hétérologue, ils présententune structure unique très compacte en double épingle qui leur apporte une grande stabilité. L’étudefonctionnelle montre que les peptides RumCs, à l’xception de RumC2, sont très efficaces contredifférents pathogènes Gram-positif et Gram-négatif. Par ailleurs, ces peptides ne présentent pas detoxicité particulière sur plusieurs cellules eucaryotes. Les peptides RumCs agissent selon un moded’action similaire qui n’implique pas la formation de pores. Par ailleurs, ils sont exclusivement actifs surdes cellules en division et ils inhibent la synthèse de l'ATP. Les travaux en cours visent à déterminer lemode d'action et à identifier la cible cellulaire. Au cours de ce projet, nous avons également mené lacaractérisation biochimique du ranthipeptide RgSCIFF et de l’enzyme radical-SAM associée. De façonintéressante, la forme modifiée du peptide RgSCIFF présente des liaisons thioéther caractéristiques desranthipeptides et des sactipeptides, ce qui en fait le premier exemple de peptide hybride.

  • Open Access

    The broad-spectrum RumC1 bacteriocin targets a transient peptidoglycan intermediate of the nascent cell wall

    by Anne Boyeldieu, Mathieu Berge, Clarisse Roblin, Lama Shamseddine, Anna M. Diaz-Rovira, Anne-Lise Soulet, Christian Basset, Lauriane Plouhinec, Agnes Amouric, Salome Milhavet, et al.

    RumC1 is a structurally unique bacteriocin with broad-spectrum efficacy, including against multidrug-resistant pathogens, yet acting by an undefined mechanism. By integrating genetics, biochemistry, computational modeling and single-cell fluorescence microscopy, we demonstrate that RumC1 is a distinct cell-wall-targeting toxin. First, all RumC1-resistant mutants isolated through a high-rate, genome-wide mutagenic screening exhibited specific impairments in peptidoglycan homeostasis regulation, pinpointing this pathway as critical for RumC1 activity. Second, RumC1 selectively accumulates within neosynthesized peptidoglycan, leading to cell growth arrest and death in a dose-dependent manner. Third, we characterize the RumIc1 immunity protein of the RumC1 biosynthetic cluster as a peptidase acting at the cell surface to protect the cells by trimming the stem peptide crucial for cell-wall assembly. As such, RumIc1 provides cross-protection against vancomycin, while RumC1 is demonstrated to act differently from this glycopeptide antibiotic. Collectively, these findings establish RumC1 as a toxin targeting a key peptidoglycan intermediate of cell wall maturation.